ROPIVACAINE HYDROCHLORIDE injection, solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

ROPIVACAINE HYDROCHLORIDE (UNII: V910P86109) (ROPIVACAINE - UNII:7IO5LYA57N)

Available from:

Gland Pharma Limited

Administration route:

INFILTRATION

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Ropivacaine Hydrochloride Injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia: epidural block for surgery including cesarean section; major nerve block; local infiltration Acute Pain Management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration Ropivacaine Hydrochloride Injection is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type. Risk Summary There are no available human data on use of ropivacaine hydrochloride Injection in pregnant women to evaluate a drug associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Local anesthetics may cause varying degrees of toxicity to the mother and fetus and adverse reactions include alterations of the central nervous system, peripheral vascular tone, and cardiac function (see Clinical Considerations) .

Product summary:

Ropivacaine Hydrochloride Injection USP is a clear colorless, and preservative-free solution available in single dose infusion bags. Storage Solutions should be stored at 20 ºC to 25 °C (68 ºF to 77 °F); [see USP Controlled Room Temperature]. Ropivacaine Hydrochloride Injection single-dose, ready-to-use, polypropylene flexible bags. The flexible bag container is not made with natural rubber latex or polyvinyl chloride (PVC), Non-DEHP. Ropivacaine Hydrochloride Injection USP container closure is not made with natural rubber latex.

Authorization status:

Abbreviated New Drug Application

Summary of Product characteristics

ROPIVACAINE HYDROCHLORIDE - ROPIVACAINE HYDROCHLORIDE INJECTION,
SOLUTION
GLAND PHARMA LIMITED
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
ROPIVACAINE
HYDROCHLORIDE INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING
INFORMATION FOR
ROPIVACAINE HYDROCHLORIDE INJECTION.
ROPIVACAINE HYDROCHLORIDE INJECTION, FOR EPIDURAL, PERINEURAL, OR
INFILTRATION USE
INITIAL U.S. APPROVAL: 1996 RX ONLY
INDICATIONS AND USAGE
Ropivacaine Hydrochloride Injection is an amide local anesthetic
indicated in adults for the production of
local or regional anesthesia for surgery and for acute pain
management.
Surgical Anesthesia: epidural block for surgery including cesarean
section; major nerve block; local
infiltration
Acute Pain Management: epidural continuous infusion or intermittent
bolus, e.g., postoperative or labor;
local infiltration (1)
DOSAGE AND ADMINISTRATION
• See Table 1 for Dosage Recommendations (2.2)
DOSAGE FORMS AND STRENGTHS
• Injection: 2 mg/mL (0.2%) in single-dose, ready-to-use,
polypropylene flexible bag (3)
CONTRAINDICATIONS
History of hypersensitivity to local anesthetics of the amide type.
(4)
WARNINGS AND PRECAUTIONS
• Delay in proper management of dose-related toxicity,
underventilation, and/or altered sensitivity may
lead to the development of acidosis, cardiac arrest and, possibly,
death. (5.1)
• In performing Ropivacaine Hydrochloride Injection blocks,
unintended intravenous injection is possible
and may result in cardiac arrhythmia or cardia arrest. (5.2)
• Intra-articular infusions of local anesthetics may cause
chondrolysis. Ropivacaine Hydrochloride Injection
is not approved for this use. (5.3).
• Signs of methemoglobinemia may occur. (5.4)
ADVERSE REACTIONS
Most common adverse reactions (incidence ≥ 5%) are hypotension,
nausea, vomiting, bradycardia, fever,
pain, postoperative complications, anemia, paresthesia, headache,
pruritus, and back pain. (6)
TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT GLAND PHARMA AT (609